Citation Tools
APCU 29 Exploring the effects of sodium-glucose cotransporter 2 inhibitor (SGLT2 inhibitor) in elderly patients with heart failure with reduced ejection fraction (HFrEF), with and without type 2 diabetes mellitus (T2DM)
Download to a citation manager
Download the citation for this article by clicking on one of the following citation managers:
- Cite this article as:
- APCU 29 Exploring the effects of sodium-glucose cotransporter 2 inhibitor (SGLT2 inhibitor) in elderly patients with heart failure with reduced ejection fraction (HFrEF), with and without type 2 diabetes mellitus (T2DM)